URGN - UroGen Pharma Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$56.60
DETAILS
HIGH:
$75.00
LOW:
$44.00
MEDIAN:
$56.00
CONSENSUS:
$56.60
UPSIDE:
53.43%
AlphaVal
Deterministic, archetype-aware fair value
AlphaVal Unavailable
AlphaVal: URGN has had negative net income and negative EPS in all 5 available fiscal year(s). Quality gate: persistently unprofitable companies are excluded.